Loay Kassem

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Metastatic Colorectal Cancer

Epidermal Growth Factor Receptor

Endoplasmic Reticulum

Decision Making

Top Venues

The breast journal

Cancer management and research

Oncology and therapy

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Hamdy A Azim, Samah A Loutfy, Hatem A Azim, Nermin S Kamal, Nasra F Abdel Fattah, Mostafa H Elberry, Mohamed R Abdelaziz, Marwa Abdelsalam, Madonna Aziz, Kyrillus S Shohdy, Loay Kassem
The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer. Oncology and therapy (2023)
Coralie Poulard, Thuy Ha Pham, Youenn Drouet, Julien Jacquemetton, Ausra Surmielova, Loay Kassem, Benoîte Mery, Christine Lasset, Jonathan Reboulet, Isabelle Treilleux, Elisabetta Marangoni, Olivier Trédan, Muriel Le Romancer
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα + breast cancer. EMBO molecular medicine (2023)
Noha Rashad, Mohamed Abdulla, Mohamed Farouk, Yasser Elkerm, Salem E Salem, Maha Yahia, Amr S Saad, Ahmed Hassan Abdel Aziz, Ghada Refaat, Ibrahim Awad, Maha ElNaggar, Khaled Kamal, Basel Refky, Mohamed Abdelkhalek, Ahmed Touny, Loay Kassem, Emad Shash, Abdelhay A Abdelhay, Bahaa Eldin Mahmoud, Karima Oualla, Nesrine Chraiet, Hussein AwadElkarim H Maki, Yasser Abdel Kader
Resource Oriented Decision Making for Treatment of Metastatic Colorectal Cancer (mCRC) in a Lower-Middle Income Country: Egyptian Foundation of Medical Sciences (EFMS) Consensus Recommendations 2020. Cancer management and research 14 (2022)
Karima Oualla, Loay Kassem, Lamiae Nouiakh, Lamiae Amaadour, Zineb Benbrahim, Samia Arifi, Nawfel Mellas
Immunotherapeutic Approaches in Triple-Negative Breast Cancer: State of the Art and Future Perspectives. International journal of breast cancer 2020 (2020)
Kyrillus S Shohdy, Hanaa Attia, Neven Mahmoud, Loay Kassem
Primary primitive neuroectodermal tumor of the breast: Analysis of clinical outcomes of twenty-one patients. The breast journal 26 (9) (2020)
Hamdy A Azim, Shaheenah Dawood, Nagi El-Saghir, Loay Kassem, Hatem A Azim
Understanding the benefits and challenges of first-line cyclin-dependent kinases 4 and 6 inhibitors in advanced breast cancer among postmenopausal women. The breast journal 26 (4) (2019)
Hanine Lattouf, Loay Kassem, Julien Jacquemetton, Ali Choucair, Coralie Poulard, Olivier Trédan, Laura Corbo, Mona Diab-Assaf, Nader Hussein, Isabelle Treilleux, Muriel Le Romancer
LKB1 regulates PRMT5 activity in breast cancer. International journal of cancer 144 (3) (2018)
Hamdy Abdel Azim, Loay Kassem, Kyrillus Samaan Shohdy, Boules Eshaak, Shady Elia Anis, Nermine Shawky Kamal
Durable Response of Androgen Receptor-Positive Male Breast Cancer to Goserelin. Journal of breast cancer 22 (1) (2018)